Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference

3 years ago

Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20th at 10:30am EDTSOUTH EASTON, MA…

Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021

3 years ago

CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…

Sean Hӓgen of BlackHӓgen Design to Present at the 2022 the [PACK](TM)out Conference

3 years ago

DUNEDIN, FL / ACCESSWIRE / April 19, 2022 / Sean Hӓgen, BlӓckHagen Design Principal, Founder, and Director of Synthesis, will…

Altamira Reaches COVAMID Trial Enrollment Midpoint for Bentrio in Acute COVID-19

3 years ago

HAMILTON, BERMUDA / ACCESSWIRE / April 19, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

Avinger Announces Full Commercial Launch of Lightbox 3

3 years ago

REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and…

Aytu BioPharma Announces Fast Track Designation Granted to AR101 for the Treatment of Vascular Ehlers-Danlos Syndrome

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

Petvivo Holdings, Inc. To Present at the Planet Microcap Showcase 2022 in Las Vegas

3 years ago

MINNEAPOLIS, MN / ACCESSWIRE / April 19, 2022 / PetVivo Holdings, Inc. (NASDAQ:PETV)(NASDAQ:PETVW) ("PetVivo") an emerging biomedical device company focused…

Marijuana Company of America Reports Year 2021 Financial Results

3 years ago

LOS ANGELES, CA / ACCESSWIRE / April 19, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,…

Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform

3 years ago

Moderna's first bivalent booster vaccine candidate, mRNA-1273.211, demonstrated superior neutralizing titers compared to mRNA-1273 against all variants of concern, including…

NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic

3 years ago

Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical EducationOAKVILLE, ON / ACCESSWIRE / April…